Chemed and Cognizant Release Future Earnings Forecasts

Chemed has forecasted its 2026 EPS to be between $25 and $25.75, with its VITAS division targeting 5.75%-6.25% ADC growth, while Cognizant projects its 2026 EPS at $5.70-$5.82 and revised its constant-currency revenue growth to 4%-5.5%.